A Review Discussing Fluciclovine ( 18 F) PET/CT Imaging in the Detection of Recurrent Prostate Cancer
- 23 January 2018
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (11) , 1101-1115
Abstract
A significant number of patients radically treated for prostate cancer (PCa) will develop prostate-specific antigen recurrence (27–53%). Localizing the anatomical site of relapse is critical, in order to achieve the optimal treatment management. To date the diagnostic accuracy of standard imaging is low. Several desirable features have been identified for the amino-acid-based PET agent, fluciclovine (18F) including: long 18F half-life which allows more practical use in centers without a cyclotron onsite; acting as a substrate for amino acid transporters upregulated in PCa or associated with malignant phenotype; lacking of incorporation into protein; and limited urinary excretion. Fluciclovine (18F) is currently approved both in USA and Europe with specific indication in adult men with suspected recurrent PCa based on elevated prostate-specific antigen following prior treatment. Lay summary Fluciclovine (18F) is a novel radiotracer for PET imaging, initially developed for neuro-oncology, then tested in a variety of tumors characterized by an increased need of amino acid uptake. Results in prostate cancer were promising. It is currently approved both in USA and Europe with specific indication in adult men with suspected recurrent prostate cancer based on elevated prostate-specific antigen, following prior treatment.Keywords
Funding Information
- Programma di ricerca Regione-Universita
This publication has 64 references indexed in Scilit:
- L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancerMolecular and Clinical Oncology, 2012
- Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical ProstatectomyClinical Nuclear Medicine, 2012
- Imaging techniques for local recurrence of prostate cancer: For whom, why and how?Diagnostic and Interventional Imaging, 2012
- 11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic CorrelationJournal of Nuclear Medicine, 2012
- Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cellsNuclear Medicine and Biology, 2012
- Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate CancerJournal of Nuclear Medicine, 2011
- Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PETNature Reviews Urology, 2009
- Biodistribution and Radiation Dosimetry of the Synthetic Nonmetabolized Amino Acid Analogue Anti-18F-FACBC in HumansJournal of Nuclear Medicine, 2007
- Positron emission tomography with c11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomyUrology, 2006
- Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?Seminars in Cancer Biology, 2005